DocGo (NASDAQ:DCGO) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded shares of DocGo (NASDAQ:DCGOFree Report) from a sell rating to a hold rating in a report published on Saturday morning.

A number of other analysts also recently commented on DCGO. Cantor Fitzgerald restated an “overweight” rating on shares of DocGo in a research note on Monday, May 11th. Stifel Nicolaus lowered their price target on DocGo from $4.00 to $2.50 and set a “buy” rating on the stock in a research report on Tuesday, March 17th. Canaccord Genuity Group lowered their price target on DocGo from $1.50 to $1.00 and set a “hold” rating on the stock in a research report on Wednesday, March 25th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $3.00 price target on shares of DocGo in a research report on Tuesday, March 17th. Three research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $2.38.

Check Out Our Latest Stock Analysis on DocGo

DocGo Stock Performance

DocGo stock opened at $0.57 on Friday. The business’s 50-day simple moving average is $0.63 and its two-hundred day simple moving average is $0.81. The company has a market cap of $56.40 million, a PE ratio of -0.30 and a beta of 1.02. DocGo has a fifty-two week low of $0.49 and a fifty-two week high of $1.78.

DocGo (NASDAQ:DCGOGet Free Report) last posted its quarterly earnings results on Monday, May 11th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.10). DocGo had a negative net margin of 62.23% and a negative return on equity of 44.09%. The firm had revenue of $75.55 million for the quarter, compared to analysts’ expectations of $72.48 million. As a group, analysts predict that DocGo will post -0.12 EPS for the current fiscal year.

Hedge Funds Weigh In On DocGo

A number of hedge funds have recently bought and sold shares of DCGO. Neuberger Berman Group LLC acquired a new position in shares of DocGo during the fourth quarter valued at approximately $29,000. Cerity Partners LLC acquired a new position in shares of DocGo during the second quarter valued at approximately $37,000. Public Employees Retirement System of Ohio acquired a new position in shares of DocGo during the fourth quarter valued at approximately $40,000. Engineers Gate Manager LP acquired a new position in shares of DocGo during the second quarter valued at approximately $52,000. Finally, Royce & Associates LP acquired a new stake in shares of DocGo in the third quarter valued at approximately $64,000. Hedge funds and other institutional investors own 56.44% of the company’s stock.

About DocGo

(Get Free Report)

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.

Featured Stories

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.